Breaking News Instant updates and real-time market news.

DOOR

Masonite

$47.76

0.82 (1.75%)

, JELD

Jeld-Wen

$14.32

0.14 (0.99%)

07:09
12/19/18
12/19
07:09
12/19/18
07:09

Masonite price target lowered to $50 from $60 at Wedbush

Wedbush analyst Jay McCanless lowered his price target for Masonite (DOOR) to $50 from $60 and reiterated a Neutral rating on the shares. The analyst cited the pending departure of long-time CEO Fred Lynch and the potential industry disruption from litigation between privately held Steve's and Sons and Jeld-Wen (JELD). McCanless is concerned Masonite may mark time until the CEO successor is announced sometime in early 2019.

DOOR

Masonite

$47.76

0.82 (1.75%)

JELD

Jeld-Wen

$14.32

0.14 (0.99%)

DOOR Masonite
$47.76

0.82 (1.75%)

10/08/18
RBCM
10/08/18
NO CHANGE
Target $76
RBCM
Masonite price target lowered to $76 from $82 at RBC Capital
RBC Capital analyst Michael Eisen lowered his price target on Masonite (DOOR) to $76, saying its industry dynamics may be impacted over the longer term by the latest U.S. District Court ruling that a divestiture of Jeld-Wen (JELD) Towanda facility would be an appropriate remedy in the antitrust litigation. As such, Eisen lowers Masonite's assumed FY19 EBITDA target multiple to 7.5-times from 8.0-times even though he keeps his Outperform rating on the shares to reflect the company's position as a "leading global door manufacturer" in both North America and U.K. residential markets.
10/09/18
NOMU
10/09/18
NO CHANGE
Target $75
NOMU
Buy
Masonite price target lowered to $75 fro $86 at Nomura Instinet
Nomura Instinet analyst Michael Wood lowered his price target for Masonite (DOOR) to $75 saying the District Court for the Eastern District of Virginia's preliminary, unfavorable ruling against Jeld-Wen (JELD) adds uncertainty. The analyst, however, keeps a Buy rating on Masonite shares.
11/13/18
WEDB
11/13/18
NO CHANGE
Target $60
WEDB
Neutral
Masonite price target lowered to $60 form $67 at Wedbush
Wedbush analyst Jay McCanless lowered his price target for Masonite to $60 from $67 as he shifts to a FY19 valuation from FY18. The analyst notes that the company's Q3 gross margin missed his mark as a result of a timing mismatch on price/cost, higher wages, and the loss of certain big box sales, and believes these factors may persist into FY19. McCanless reiterates a Neutral rating on the shares.
11/28/18
JPMS
11/28/18
NO CHANGE
JPMS
JPMorgan remains cautious on Homebuilders after new home sales miss
JPMorgan analyst Michael Rehaut remains cautious on Homebuilding stocks after October new home sales fell 9%, below the Street's estimate of 4%. The analyst expects a "fairly tepid" recovery in housing starts to continue in 2019 and believes the current softness may last for a few more months. Further, he thinks builder fundamentals will moderate over the next two years. His Overweight-rated builders include Lennar (LEN), LGI Homes (LGIH) and William Lyon Homes (WLH). His Overweight-rated names in building products include Masonite (DOOR), Fortune Brands (FBHS) and Stanley Black & Decker (SWK).
JELD Jeld-Wen
$14.32

0.14 (0.99%)

11/07/18
WELS
11/07/18
NO CHANGE
Target $19
WELS
Market Perform
Jeld-Wen price target lowered to $19 form $29 at Wells Fargo
Wells Fargo lowered its price target for Jeld-Wen to $19 from $29 as it believes the equity will remain in the penalty box as the ongoing North American and European issues for most of its public life have created significant skepticism around its forecasts. Ultimately, Jeld-Wen likely needs a few quarters of consistent, improved fundamental performance before investor confidence is restored, the firm contends. Wells Fargo has a Market Perform rating on the shares.
12/03/18
WELS
12/03/18
NO CHANGE
WELS
China tariff deal a benefit for most building products companies, says Wells Fargo
Wells Fargo analyst Stephen East notes the White House announced that the U.S. would, for the time being, leave the tariff rate at 10% on $200B of Chinese goods, instead of bumping the rate to 25% on January 1st. Previously, the analyst had assumed the 25% tariff would create a material headwind for Masco (MAS), followed by American Woodmark (AMWD), Fortune Brands (FBHS) and Jeld-Wen (JELD) and PGT Innovations (PGTI), with little impact on Sherwin-Williams (SHW) and Owens Corning (OC). Mohawk (MHK) will have unquantified headwinds, but has the most U.S. manufacturing capacity, ultimately providing a net benefit versus peers, he adds. With the U.S. halting the hike to a 25% tariff rate, East believes Masco will receive the greatest reprieve, followed by Fortune Brands and Jeld-Wen. Net, he thinks the deal is a modest headwind for Mohawk's equity as Chinese flooring imports will remain more competitive.
12/09/18
GSCO
12/09/18
DOWNGRADE
GSCO
Neutral
Jeld-Wen downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Doug Clark downgraded Jeld-Wen to Neutral.
12/10/18
GSCO
12/10/18
DOWNGRADE
GSCO
Neutral
Jeld-Wen downgraded to Neutral at Goldman Sachs on housing macro risk
As reported earlier, Goldman Sachs analyst Doug Clark downgraded Jeld-Wen from Buy to Neutral as part of his broader research note on stocks with exposure to the "lumpy" housing sector. The analyst believes that there is "ample room for margin expansion", but adds that his prior initiation on the stock at Buy was likely premature since that expansion will not "contribute meaningfully to earnings until 2020". Clark further states that the positive catalyst he expected from Jeld-Wen's "announcement of a restructuring and some further visibility on the Steves litigation" will take longer to play out than he anticipated.

TODAY'S FREE FLY STORIES

MS

Morgan Stanley

$42.16

-0.24 (-0.57%)

07:21
01/24/19
01/24
07:21
01/24/19
07:21
Hot Stocks
Morgan Stanley CEO: Shutdown could have 'extremely damaging' impact »

Gorman is speaking to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAH

Platform Specialty Products

$10.90

-0.15 (-1.36%)

07:19
01/24/19
01/24
07:19
01/24/19
07:19
Hot Stocks
Platform Specialty Products receives regulatory approval for Arysta sale »

Platform Specialty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MB

Mindbody

$36.41

-0.19 (-0.52%)

07:19
01/24/19
01/24
07:19
01/24/19
07:19
Downgrade
Mindbody rating change  »

JMP downgrades Mindbody…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PANW

Palo Alto Networks

$205.77

2.77 (1.36%)

07:18
01/24/19
01/24
07:18
01/24/19
07:18
Upgrade
Palo Alto Networks rating change  »

Palo Alto Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Feb

PG

Procter & Gamble

$94.87

4.37 (4.83%)

07:18
01/24/19
01/24
07:18
01/24/19
07:18
Recommendations
Procter & Gamble analyst commentary  »

Procter & Gamble…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 03

    Mar

NMCI

Navios Maritime Containers

$3.03

(0.00%)

07:17
01/24/19
01/24
07:17
01/24/19
07:17
Hot Stocks
Navios Maritime Containers exercises option to acquire containership for $52.5M »

Navios Maritime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAPR

Capricor Therapeutics

$0.58

-0.0751 (-11.46%)

07:17
01/24/19
01/24
07:17
01/24/19
07:17
Hot Stocks
Capricor Therapeutics announces HOPE-Duchenne trial results published »

Neurology, an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXN

Texas Instruments

$95.49

-1.05 (-1.09%)

07:17
01/24/19
01/24
07:17
01/24/19
07:17
Recommendations
Texas Instruments analyst commentary  »

Texas Instruments price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

NESRF

Northern Star Resources

$0.00

(0.00%)

07:16
01/24/19
01/24
07:16
01/24/19
07:16
Downgrade
Northern Star Resources rating change  »

Northern Star Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:15
01/24/19
01/24
07:15
01/24/19
07:15
General news
FX Update: The dollar has posted advances »

FX Update: The dollar has…

EEX

Emerald Expositions Events

, RELX

RELX

$21.78

-0.03 (-0.14%)

07:14
01/24/19
01/24
07:14
01/24/19
07:14
Recommendations
Emerald Expositions Events, RELX analyst commentary  »

Emerald Expositions a…

EEX

Emerald Expositions Events

RELX

RELX

$21.78

-0.03 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$94.87

4.37 (4.83%)

, EL

Estee Lauder

$126.94

1.19 (0.95%)

07:14
01/24/19
01/24
07:14
01/24/19
07:14
Recommendations
Procter & Gamble, Estee Lauder, Church & Dwight analyst commentary  »

P&G report has…

PG

Procter & Gamble

$94.87

4.37 (4.83%)

EL

Estee Lauder

$126.94

1.19 (0.95%)

CHD

Church & Dwight

$65.45

-0.7 (-1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 05

    Feb

  • 18

    Feb

  • 03

    Mar

  • 28

    May

USAP

Universal Stainless & Alloy

$14.62

-0.515 (-3.40%)

07:14
01/24/19
01/24
07:14
01/24/19
07:14
Hot Stocks
Universal Stainless & Alloy increases low alloy VAR bar base price 5%-10% »

Universal Stainless &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLNX

Xilinx

$89.55

-0.89 (-0.98%)

07:12
01/24/19
01/24
07:12
01/24/19
07:12
Recommendations
Xilinx analyst commentary  »

Xilinx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

CNOB

ConnectOne Bancorp

$20.08

-0.19 (-0.94%)

07:11
01/24/19
01/24
07:11
01/24/19
07:11
Earnings
ConnectOne Bancorp reports Q4 adj. EPS 59c, consensus 55c »

As of December 31, 2018,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

AEP

American Electric

$77.00

0.65 (0.85%)

07:11
01/24/19
01/24
07:11
01/24/19
07:11
Earnings
Breaking Earnings news story on American Electric »

American Electric backs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

AEP

American Electric

$77.00

0.65 (0.85%)

07:10
01/24/19
01/24
07:10
01/24/19
07:10
Earnings
American Electric reports Q4 EPS 74c, consensus 71c »

Reports Q4 revenue $3.8B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

LVS

Las Vegas Sands

$57.25

0.26 (0.46%)

07:10
01/24/19
01/24
07:10
01/24/19
07:10
Recommendations
Las Vegas Sands analyst commentary  »

Las Vegas Sands price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

CNCE

Concert Pharmaceuticals

$14.02

-0.26 (-1.82%)

07:10
01/24/19
01/24
07:10
01/24/19
07:10
Hot Stocks
Concert Pharmaceuticals initiates Phase 1 single-ascending dose trial of CTP-692 »

Concert Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 30

    Jan

  • 12

    Feb

  • 13

    Feb

MDR

McDermott

$8.49

0.01 (0.12%)

07:09
01/24/19
01/24
07:09
01/24/19
07:09
Hot Stocks
McDermott announces ethylene furnace award in Indonesia »

McDermott announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

BWB

Bridgewater Bancshares

$10.41

-0.17 (-1.61%)

07:09
01/24/19
01/24
07:09
01/24/19
07:09
Earnings
Bridgewater Bancshares reports Q4 EPS 25c, two est. 23c »

The fourth quarter of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLDC

China Lending Corp.

$1.11

-0.005 (-0.45%)

07:09
01/24/19
01/24
07:09
01/24/19
07:09
Hot Stocks
China Lending Corp. acquires minority interest in financial service company »

China Lending Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

RCI

Rogers Communications

$54.51

-0.12 (-0.22%)

07:09
01/24/19
01/24
07:09
01/24/19
07:09
Earnings
Rogers Communications sees FY19 revenue up 3%-5% »

Sees FY19 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

LIVX

LiveXLive Media

$6.25

-0.05 (-0.79%)

07:08
01/24/19
01/24
07:08
01/24/19
07:08
Recommendations
LiveXLive Media analyst commentary  »

LiveXLive Media price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRIS

Curis

$1.06

-0.045 (-4.09%)

07:08
01/24/19
01/24
07:08
01/24/19
07:08
Hot Stocks
Curis says first mesothelioma patient dosed in CA-170 study »

Curis announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.